N/A
N=181
Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic
Type 2 Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT04876274 ↗Enrolled (actual)
181
Serious AEs
—
Results posted
Dec 2021
Primary outcome: Primary: HbA1C — 7.0; 6.7 % of HbA1C
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- TMU-LOVE (Behavioral)
- Age
- Adult, Older Adult · 20+ yrs
- Sex
- All
- Sponsor
- Taipei Medical University
- Primary completion
- Dec 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY HbA1C |
7.0; 6.7 | — |
| SECONDARY Score of Diabetes Care Profile-Attitudes Toward Diabetes Scales |
3.8; 3.7 | — |
| SECONDARY Score of Summary of Diabetes Self-Care Activities |
4.0; 3.9 | — |
| SECONDARY Score of Simplified True / False Version of Diabetes Knowledge Scale |
76.7; 73.2 | — |
Summary
The current study was to develop a software "Line@" based health education program, providing video-based health information and communication between diabetes patients and health-care professionals. This study also evaluated its effectiveness on improving glycemic control, attitude towards diabetes, knowledge about diabetes and self-care for type 2 diabetes patients in Taiwan.
The followings were the hypotheses of the study:
1. Compared to the control group, intervention group receiving "Line" based video education has a greater improvement on glycosylated hemoglobin (A1C).
2. Compared to the control group, intervention group receiving "Line" based video education has a greater positive effect on attitude towards diabetes.
3. Compared to the control group, intervention group receiving "Line" based video education has a better understanding on diabetic knowledge.
4. Compared to the control group, intervention group receiving "Line" based video education has a greater positive effect on self-care activity.
Eligibility Criteria
Inclusion Criteria
- Type 2 Diabetes mellitus (T2DM)
- Age 20 or older
- Had at least 1 A1C data in the past 6 months
- Possessed a smart-cellphone
- A1C ≥ 6%
Exclusion Criteria
- Gestational diabetes
- Cognitive impairment
- No medication treatment but dietary control alone
Data sourced from ClinicalTrials.gov (NCT04876274). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.